Country Club Trust Company n.a. decreased its position in Novartis AG (NYSE:NVS) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 67,861 shares of the company’s stock after selling 4,798 shares during the period. Country Club Trust Company n.a.’s holdings in Novartis were worth $5,697,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of NVS. Hall Laurie J Trustee grew its position in shares of Novartis by 0.3% during the 2nd quarter. Hall Laurie J Trustee now owns 16,713 shares of the company’s stock valued at $1,395,000 after acquiring an additional 50 shares during the period. Sunbelt Securities Inc. grew its position in shares of Novartis by 1.8% during the 2nd quarter. Sunbelt Securities Inc. now owns 5,013 shares of the company’s stock valued at $418,000 after acquiring an additional 90 shares during the period. Roberts Glore & Co. Inc. IL grew its position in shares of Novartis by 1.3% during the 2nd quarter. Roberts Glore & Co. Inc. IL now owns 12,705 shares of the company’s stock valued at $1,060,000 after acquiring an additional 165 shares during the period. Courier Capital LLC grew its position in shares of Novartis by 3.5% during the 2nd quarter. Courier Capital LLC now owns 4,965 shares of the company’s stock valued at $414,000 after acquiring an additional 170 shares during the period. Finally, Logan Capital Management Inc. grew its position in shares of Novartis by 1.6% during the 2nd quarter. Logan Capital Management Inc. now owns 12,861 shares of the company’s stock valued at $1,073,000 after acquiring an additional 200 shares during the period. Hedge funds and other institutional investors own 10.85% of the company’s stock.

A number of research firms have recently weighed in on NVS. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Novartis in a research report on Tuesday, October 24th. Nord/LB reissued a “neutral” rating on shares of Novartis in a research report on Tuesday, January 2nd. Bank of America downgraded shares of Novartis from a “neutral” rating to an “underperform” rating in a research report on Wednesday, December 6th. Leerink Swann increased their target price on shares of Novartis from $89.00 to $91.00 and gave the company a “market perform” rating in a research report on Monday, October 23rd. Finally, Zacks Investment Research downgraded shares of Novartis from a “buy” rating to a “hold” rating in a research report on Friday, October 6th. Five investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company. Novartis currently has a consensus rating of “Hold” and a consensus price target of $85.32.

Novartis AG (NYSE:NVS) traded up $1.01 on Friday, reaching $86.68. 831,754 shares of the company traded hands, compared to its average volume of 990,200. The company has a market cap of $225,470.00, a P/E ratio of 30.85, a PEG ratio of 2.55 and a beta of 0.74. Novartis AG has a 52 week low of $69.53 and a 52 week high of $86.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.81 and a current ratio of 1.08.

Novartis (NYSE:NVS) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.29 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.25 by $0.04. The company had revenue of $12.41 billion during the quarter, compared to the consensus estimate of $12.21 billion. Novartis had a net margin of 13.73% and a return on equity of 15.77%. Novartis’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same period last year, the firm earned $1.23 EPS. equities analysts anticipate that Novartis AG will post 4.77 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Country Club Trust Company n.a. Has $5.70 Million Holdings in Novartis AG (NVS)” was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.watchlistnews.com/country-club-trust-company-n-a-has-5-70-million-holdings-in-novartis-ag-nvs/1804652.html.

About Novartis

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.

Want to see what other hedge funds are holding NVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novartis AG (NYSE:NVS).

Institutional Ownership by Quarter for Novartis (NYSE:NVS)

Receive News & Ratings for Novartis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis and related companies with MarketBeat.com's FREE daily email newsletter.